HubXchange Oncology Companion Diagnostics EUROPE: June 29, 2022
Presentation
Wednesday, June 29 | 11:20am – 12:20pm CEST
Beyond MRD: Developing Patient-Centered Diagnostics through Tumor-Informed Comprehensive Insights
Presenter: Ted van der Lende, PhD
Executive Director, Europe Business Development
Description:
- Earlier detection of disease recurrence
- Utility in more disease indications, and at earlier stages of disease
- Clinical trial needs for patient enrichment
- Screening/enrollment
- Surrogate endpoint analysis
- Necessity for additional biomarker readouts
HubXchange Oncology Companion Diagnostics EUROPE
